Diamedica Therapeutics Stock Market Value

DMAC Stock  USD 2.39  0.04  1.65%   
DiaMedica Therapeutics' market value is the price at which a share of DiaMedica Therapeutics trades on a public exchange. It measures the collective expectations of DiaMedica Therapeutics investors about its performance. DiaMedica Therapeutics is trading at 2.39 as of the 16th of April 2024, a -1.65 percent decrease since the beginning of the trading day. The stock's open price was 2.43.
With this module, you can estimate the performance of a buy and hold strategy of DiaMedica Therapeutics and determine expected loss or profit from investing in DiaMedica Therapeutics over a given investment horizon. Check out DiaMedica Therapeutics Correlation, DiaMedica Therapeutics Volatility and DiaMedica Therapeutics Alpha and Beta module to complement your research on DiaMedica Therapeutics.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.
Symbol

DiaMedica Therapeutics Price To Book Ratio

Is DiaMedica Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.60)
Return On Assets
(0.30)
Return On Equity
(0.47)
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

DiaMedica Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DiaMedica Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DiaMedica Therapeutics.
0.00
03/17/2024
No Change 0.00  0.0 
In 30 days
04/16/2024
0.00
If you would invest  0.00  in DiaMedica Therapeutics on March 17, 2024 and sell it all today you would earn a total of 0.00 from holding DiaMedica Therapeutics or generate 0.0% return on investment in DiaMedica Therapeutics over 30 days. DiaMedica Therapeutics is related to or competes with Milestone Pharmaceuticals, Seres Therapeutics, Inhibikase TherapeuticsInc, Oncolytics Biotech, Scpharmaceuticals, ATyr Pharma, and Lyra TherapeuticsInc. DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney... More

DiaMedica Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DiaMedica Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DiaMedica Therapeutics upside and downside potential and time the market with a certain degree of confidence.

DiaMedica Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for DiaMedica Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DiaMedica Therapeutics' standard deviation. In reality, there are many statistical measures that can use DiaMedica Therapeutics historical prices to predict the future DiaMedica Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DiaMedica Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.122.375.69
Details
Intrinsic
Valuation
LowRealHigh
0.463.787.10
Details
2 Analysts
Consensus
LowTargetHigh
7.588.339.25
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.16-0.16-0.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DiaMedica Therapeutics. Your research has to be compared to or analyzed against DiaMedica Therapeutics' peers to derive any actionable benefits. When done correctly, DiaMedica Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DiaMedica Therapeutics.

DiaMedica Therapeutics Backtested Returns

DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0535, which denotes the company had a -0.0535% return per unit of standard deviation over the last 3 months. DiaMedica Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm DiaMedica Therapeutics' Coefficient Of Variation of (1,148), standard deviation of 3.28, and Mean Deviation of 2.51 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.33, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, DiaMedica Therapeutics will likely underperform. DiaMedica Therapeutics has an expected return of -0.18%. Please make sure to confirm DiaMedica Therapeutics total risk alpha, potential upside, and the relationship between the standard deviation and maximum drawdown , to decide if DiaMedica Therapeutics performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.05  

Very weak reverse predictability

DiaMedica Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between DiaMedica Therapeutics time series from 17th of March 2024 to 1st of April 2024 and 1st of April 2024 to 16th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DiaMedica Therapeutics price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current DiaMedica Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient-0.05
Spearman Rank Test-0.12
Residual Average0.0
Price Variance0.03

DiaMedica Therapeutics lagged returns against current returns

Autocorrelation, which is DiaMedica Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DiaMedica Therapeutics' stock expected returns. We can calculate the autocorrelation of DiaMedica Therapeutics returns to help us make a trade decision. For example, suppose you find that DiaMedica Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

DiaMedica Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DiaMedica Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DiaMedica Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DiaMedica Therapeutics stock over time.
   Current vs Lagged Prices   
       Timeline  

DiaMedica Therapeutics Lagged Returns

When evaluating DiaMedica Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DiaMedica Therapeutics stock have on its future price. DiaMedica Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DiaMedica Therapeutics autocorrelation shows the relationship between DiaMedica Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in DiaMedica Therapeutics.
   Regressed Prices   
       Timeline  

Pair Trading with DiaMedica Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DiaMedica Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against DiaMedica Stock

  0.5MRNA Moderna Financial Report 2nd of May 2024 PairCorr
  0.45INDP Indaptus Therapeutics Financial Report 9th of May 2024 PairCorr
  0.42RZLT Rezolute TrendingPairCorr
The ability to find closely correlated positions to DiaMedica Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DiaMedica Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DiaMedica Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DiaMedica Therapeutics to buy it.
The correlation of DiaMedica Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DiaMedica Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DiaMedica Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DiaMedica Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DiaMedica Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DiaMedica Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Diamedica Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Diamedica Therapeutics Stock:
Check out DiaMedica Therapeutics Correlation, DiaMedica Therapeutics Volatility and DiaMedica Therapeutics Alpha and Beta module to complement your research on DiaMedica Therapeutics.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.
Note that the DiaMedica Therapeutics information on this page should be used as a complementary analysis to other DiaMedica Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for DiaMedica Stock analysis

When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stocks Directory
Find actively traded stocks across global markets
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DiaMedica Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DiaMedica Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...